Multimodality vendor Picker International of Cleveland has formed a new oncology division to integrate the company’s various technologies into new advanced treatment planning systems. Picker already has a 70% share of the treatment planning market
Multimodality vendor Picker International of Cleveland has formed a new oncology division to integrate the companys various technologies into new advanced treatment planning systems. Picker already has a 70% share of the treatment planning market with its Acqsim 3-D CT treatment planning system, and Picker hopes to incorporate other modalities, such as x-ray, MRI, and ultrasound, into its treatment planning offerings.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.